These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 10557410)

  • 1. The Food and Drug Administration and atrial defibrillation devices.
    Chen L; Keane AT; Every NR
    Am J Manag Care; 1999 Jul; 5(7):899-909. PubMed ID: 10557410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atrial defibrillator].
    Jung W; Lüderitz B
    Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology assessment of medical devices at the Center for Devices and Radiological Health.
    Kessler L; Richter K
    Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of pacemaker and defibrillator therapy for the treatment of atrial fibrillation.
    Mitchell AR
    Minerva Cardioangiol; 2004 Apr; 52(2):141-53. PubMed ID: 15194995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA medical device approval: things you didn't learn in medical school or residency.
    Buch B
    Am J Orthop (Belle Mead NJ); 2007 Aug; 36(8):407-12. PubMed ID: 17849025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable atrial defibrillator for atrial fibrillation.
    Sra J; Jazayeri MR; Dhala A; Blanck Z; Deshpande S; Akhtar M
    WMJ; 1998 Nov; 97(10):37-6. PubMed ID: 9855792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices: cardiovascular devices: reclassification of the arrhythmia detector and alarm. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Oct; 68(208):61342-4. PubMed ID: 14584507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation in the new millennium--the role of pacemaker and defibrillator therapy.
    Mitchell AR
    Med Sci Monit; 2002 Oct; 8(10):RA233-9. PubMed ID: 12388933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making sense of the food and drug administration.
    Connor JA
    Semin Pediatr Surg; 2006 Nov; 15(4):293-301. PubMed ID: 17055960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nightmare of FDA clearance/approval to market: perception or reality?
    Tylenda CA
    Technol Health Care; 1996 Sep; 4(3):259-67. PubMed ID: 8931236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the implantable atrial cardioverter-defibrillator.
    Santini M
    Ital Heart J; 2005 Mar; 6(3):206-9. PubMed ID: 15875510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of preimplantation procedures in candidates for an implantable atrial defibrillator.
    Seidl K; Hauer B; Kirca M; Drögemüller A; Werling C; Schwacke H; Zahn R; Saggau W; Senges J
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S127-31. PubMed ID: 9727687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FDA's role in medical device clinical studies of human subjects.
    Saviola J
    J Neural Eng; 2005 Mar; 2(1):S1-4. PubMed ID: 15876645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using the MADIT II criteria for implantable cardioverter defibrillators-what is the role of the Food and Drug Administration approval?
    Barold HS
    Card Electrophysiol Rev; 2003 Dec; 7(4):443-6. PubMed ID: 15071272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical devices; refurbishers, rebuilders, reconditioners, servicers, and "as is" remarketers of medical devices; review and revision of compliance policy guides and regulatory requirements; request for comments and information--FDA. Advance notice of proposed rulemaking.
    Fed Regist; 1997 Dec; 62(246):67011-3. PubMed ID: 10179309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint.
    Boriani G; Diemberger I; Biffi M; Martignani C; Ziacchi M; Bertini M; Valzania C; Bronzetti G; Rapezzi C; Branzi A
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):422-33. PubMed ID: 17367364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Food and Drug Administration-approved endovascular repair devices for abdominal aortic aneurysms: a review.
    Tan JW; Yeo KK; Laird JR
    J Vasc Interv Radiol; 2008 Jun; 19(6 Suppl):S9-S17. PubMed ID: 18502391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioversion for atrial fibrillation: treatment options and advances.
    Reiffel JA
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):1073-84. PubMed ID: 19659629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the U.S. Food and Drug Administration in device evaluation and monitoring.
    ; Diehl DL; Tierney WM; Adler DG; Conway JD; Farraye FA; Kantsevoy SV; Kaul V; Kethu SR; Kwon RS; Mamula P; Pedrosa MC; Rodriguez SA
    Gastrointest Endosc; 2010 Jul; 72(1):5-10. PubMed ID: 20421100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The medical device payment controversy rages on.
    Brown E
    Physician Exec; 1995 Nov; 21(11):40-1. PubMed ID: 10153735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.